Last update 12 Apr 2025

Ciprofloxacin Hydrochloride Liposomal

Overview

Basic Info

Drug Type
Small molecule drug, Liposomal Drug
Synonyms-
Target
Bacterial DNA gyrase x Bacterial top IV
Action
inhibitors
Mechanism
Bacterial DNA gyrase inhibitors(Bacterial DNA gyrase inhibitors), Bacterial top IV inhibitors(Bacterial topoisomerase IV inhibitors)
Therapeutic Areas
Respiratory DiseasesInfectious Diseases
Active Indication-
Inactive Indication
BronchiectasisPseudomonas aeruginosa infection
Originator Organization
Aradigm Corp.Aradigm Corp.
Active Organization-
Inactive Organization
Aradigm Corp.Aradigm Corp.
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Ciprofloxacin Hydrochloride Liposomal
ACTRN12609000544279
/ CompletedPhase 1
A single dose, 3-way cross-over study comparing the safety, tolerability and pharmacokinetics of two inhaled Liposomal Ciprofloxacin Hydochloride (HCl) for Inhalation formulations in two different nebulizers in healthy adults, with single dose assessment in subjects with non-Cystic Fibrosis (CF) bronchiectasis.
EUCTR2008-000264-17-GB
/ Not yet recruitingNot Applicable
A MULTI-CENTER, OPEN-LABEL, PROOF-OF-CONCEPT STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND EFFECT ON SPUTUM PSEUDOMONAS AERUGINOSA DENSITY OF INHALED LIPOSOMAL CIPROFLOXACIN HYDROCHLORIDE IN ADULT SUBJECTS WITH NON-CF BRONCHIECTASIS - Not available
100 Clinical Results associated with Ciprofloxacin Hydrochloride Liposomal
Login to view more data
100 Translational Medicine associated with Ciprofloxacin Hydrochloride Liposomal
Login to view more data
100 Patents (Medical) associated with Ciprofloxacin Hydrochloride Liposomal
Login to view more data
100 Deals associated with Ciprofloxacin Hydrochloride Liposomal
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
BronchiectasisPhase 1
Australia
Aradigm Corp.Aradigm Corp.
16 Mar 2009
Pseudomonas aeruginosa infectionClinical
United Kingdom
Aradigm Corp.Aradigm Corp.
19 Aug 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free